RSS

Innovate UK

Ubiquigent — a company focused on enabling and supporting ubiquitin system targeted drug discovery — has been awarded a new grant from Innovate UK. more

News

Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. more

News

A Small Business Research Initiative (SBRI) competition has been launched by the government to encourage development of innovative solutions to the antimicrobial resistance (AMR) crisis in humans. more

News

Evonetix, a Cambridge-based company, has been awarded substantial funding from Innovate UK, the UK’s innovation agency, to support the development of a novel enzymatic approach to DNA synthesis. more

News

Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. more

News

Emergex Vaccines Holding (Emergex) — a biotechnology company — has been awarded with a grant of £979,318 from Innovate UK to progress its universal flu vaccine programme through preclinical development. more

News

The UCL Technology Fund (UCLTF) and UK Innovation & Science Seed Fund (UKI2S), with support from Innovate UK, have invested in cell therapy company Glialign — a spin out company from UCL. more

News

Cancer immune-oncology company, NeoPhore, and developer of a next-generation phenotypic screening platform, PhoreMost, have been granted funding from Innovate UK in support of the development of novel small-molecule cancer immunotherapy programme. more

News

Biopharmaceutical company, Oppilotech, has been awarded with a grant from Innovate UK to expand its computational model of the outer wall of Gram-negative bacteria. more

News

UK-based developer of cell-based therapeutics, ReNeuron Group, has won a grant to advance the development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina. more

News

TrakCel, software developer for gene therapy supply chain tracking and orchestration, has announced it will be organisation that is responsible for tracking and documentation of cell and gene therapy products for the Northern Alliance more

News

Contract CRO, Aptus Clinical, is to be one of 12 partners to receive government funding that will be used to ensure more patients benefit from a new generation of disease-fighting medicines for cancer and non-cancer illnesses more

News

UK-based biopharmaceutical company, Autolus, has announced its participation in the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) and support of the Innovate Manchester Advanced Therapy Centre Hub (iMATCH) consortium. more

News

Innovate UK, the country’s innovation agency, has awarded a grant to Aseptika and Zenzium for the development of a new home-based early warning system, using artificial intelligence (AI), for people with severe respiratory disease. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

UK-based biotechnology company, Stabilitech Biopharma, has received further funding from Innovate UK to develop its oral Zika virus vaccine so that it is first-in-human ready by 2020. more

News

International CDMO of biologics and pharmaceuticals, Cobra Biologics, and CMO specialising in sterile fill finish, Symbiosis Pharmaceutical Services, have been awarded a collaborative grant of £1.9 million from Innovate UK. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Privately-owned drug discovery services company, Domainex, has been granted a £118,000 award from Innovate UK to develop a new biophysical screening method for G-protein coupled receptors (GPCRs). more

News

BioMoti, Pharmidex and Queen Mary University of London (QMUL) have been announced as the awardee of the Biomedical Catalyst funding for the support of preclinical studies of new therapeutic approaches for hard-to-treat tumours. more

News